SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIbstock Regulatory News (IBST)

Share Price Information for Ibstock (IBST)

Share Price is delayed by 15 minutes
Get Live Data
95.00    3.15 (3.43%)
Bid:
95.05
Ask:
95.60
Spread: 0.55 (0.579%)
Market Cap: £375.27m
IBST Live PriceLast checked at - London Stock Exchange

Intraday Ibstock Share Chart

Ibstock plc Pre-Stabilisation Notice

22 Oct 2015 07:06

RNS Number : 0406D
UBS Limited
21 October 2015
 

Pre-stabilisation announcement

 

 

Not for distribution, directly or indirectly, in or into the United States, Canada, Japan or Australia or any jurisdiction in which such distribution would be unlawful.

 

 

Ibstock plc

Stabilisation Notice

 

22 October 2015

 

UBS Limited (contact: Gareth McCartney; telephone: 0044 20756 82227) hereby gives notice that the Stabilisation Manager named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6) and MAR 2.3.5 (1) of the Financial Conduct Authority Code of Market Conduct

 

The Securities:

Issuer:

Ibstock plc

Offering securities:

Ordinary shares of £0.01 each

ISIN: GB00BYXJC278

Offering description:

Initial public offering of Ordinary Shares

Offering size:

162,200,000 ordinary shares ("Ordinary Shares") (excluding over-allotment option)

Offer price:

190 pence per Ordinary Share

Stabilisation:

Stabilisation Manager:

UBS Limited, 1 Finsbury Avenue, London EC2M 2PP, United Kingdom

 

Stabilisation period expected to start on:

Approximately 8.00 a.m. (London time) on 22 October 2015

Stabilisation period expected to end no later than:

Close of business on 20 November 2015

Maximum size of over-allotment facility:

24,330,000 Ordinary Shares

Conditions of use of over-allotment facility:

 

May be exercised in whole or in part by the Stabilisation Manager, to the extent permitted by applicable law, at any time during the period commencing with conditional dealings and ending 30 days thereafter

Over-allotment Option:

Terms:

Diamond (BC) S.à r.l., an indirect subsidiary of Bain Capital Europe LLP, has granted UBS Limited, in its capacity as stabilisation manager, and for the account of the underwriters, the option to acquire up to an additional 24,330,000 Ordinary Shares at the Offer Price (representing up to 15 per cent of the offer size)

Exercise period:

30 days from the start of conditional dealings (ending close of business 20 November 2015)

 

 

 

In connection with the offer of the above securities, the Stabilisation Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

The offer of the above securities and the distribution of this announcement and other information in connection with the offer of the above securities in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAGMMZGLMRGKZM
Date   Source Headline
22nd May 20269:00 amRNSHolding(s) in Company
21st May 20261:51 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Trading Update
14th May 202611:00 amRNSHolding(s) in Company
13th May 20263:55 pmRNSHolding(s) in Company
13th May 20263:39 pmRNSHolding(s) in Company
1st May 20268:26 amRNSTotal Voting Rights
29th Apr 20264:11 pmRNSHolding(s) in Company
21st Apr 20262:38 pmRNSDirector/PDMR Shareholding
21st Apr 20267:03 amRNSAppointment of Chief Financial Officer
17th Apr 202611:00 amRNSDirector/PDMR Shareholding
10th Apr 20263:00 pmRNSDirector/PDMR Shareholding
1st Apr 20269:04 amRNSTotal Voting Rights
25th Mar 20269:16 amRNSNotice of AGM
24th Mar 20262:17 pmRNSHolding(s) in Company
17th Mar 20264:00 pmRNSDirector/PDMR Shareholding
11th Mar 20263:15 pmRNSHolding(s) in Company
6th Mar 20263:00 pmRNSHolding(s) in Company
5th Mar 20267:01 amRNSAppointment of Non-Executive Director
5th Mar 20267:00 amRNSResults for the year ended 31 December 2025
2nd Mar 202610:02 amRNSTotal Voting Rights
25th Feb 202610:00 amRNSHolding(s) in Company
2nd Feb 20264:21 pmRNSTotal Voting Rights
22nd Jan 20268:55 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
12th Jan 20262:51 pmRNSHolding(s) in Company
2nd Jan 202610:00 amRNSBlock listing Six Monthly Return
11th Dec 20253:00 pmRNSHolding(s) in Company
13th Nov 20252:00 pmRNSRefinancing of £125m revolving credit facility
10th Oct 20257:00 amRNSThird Quarter Trading Update
2nd Oct 202510:00 amRNSDirectorate Change
1st Oct 20258:04 amRNSTotal Voting Rights
26th Sep 20252:30 pmRNSHolding(s) in Company
16th Sep 20252:00 pmRNSDirector/PDMR Shareholding
29th Aug 20253:30 pmRNSHolding(s) in Company
29th Aug 202510:00 amRNSHolding(s) in Company
22nd Aug 202512:21 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSInterim Results
30th Jul 20252:00 pmRNSHolding(s) in Company
18th Jul 202511:00 amRNSHolding(s) in Company
15th Jul 20257:00 amRNSNotice of Results
10th Jul 20259:30 amRNSHolding(s) in Company
4th Jul 20259:30 amRNSHolding(s) in Company
3rd Jul 20253:00 pmRNSBlock listing Interim Review
3rd Jul 202512:00 pmRNSTotal Voting Rights
3rd Jul 20259:30 amRNSHolding(s) in Company
23rd Jun 20258:26 amRNSReport on Payments to Govts
20th Jun 202512:31 pmRNSDirector/PDMR Shareholding
12th Jun 20253:00 pmRNSHolding(s) in Company
12th Jun 20252:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.